In various experimental models of colitis in rats, administration of the A2AR agonist polydeoxyribonucleotide restores tissue structural integrity by reducing inflammatory cytokine expression, myeloperoxidase activity, and malondialdehyde. This evidence concerns the gene ADORA2A and colitis.